Rapamycin/sirolimus (SR), trade named Rapammune (Wyeth-Ayerst, Sydney, Australia), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and infection.
hypertension
sirolimus
hyperlipidemia
sirolimus
hyperlipidemia
Rapamycin
myelosuppression
SR
hypertension
Rapamycin
infection
SR
hypertension
SR
infection
Rapammune
myelosuppression
Rapamycin
hypertension
Rapammune
infection
sirolimus
hyperlipidemia
Rapammune
infection
Rapamycin
myelosuppression
Rapammune
hyperlipidemia
SR
myelosuppression
sirolimus